Topotecan

Topotecan is a strong medicine used to treat certain types of cancer, like ovarian cancer. It works by stopping cancer cells from dividing. It's given in a hospital setting.

Brand names:Hycamtin
Medication

What people taking Topotecan report

Every report comes from a Lived member, sent anonymously.

Have you tried Topotecan for Small Cell Lung Cancer?

NameHow it went

About Topotecan

What It's For

Topotecan is a chemotherapy medicine used for certain cancers that have come back or kept growing after earlier treatment. It is sold under the brand name Hycamtin and as generic topotecan. It comes in two forms with different approved uses. The intravenous (IV) form is approved for ovarian cancer that has spread and progressed during or after chemotherapy, and for small cell lung cancer that responded to first-line platinum-based chemotherapy but returned at least 60 days after that treatment began. Given together with cisplatin, another chemotherapy drug, it is also approved for advanced cervical cancer (stage IV-B, recurrent or persistent) that surgery or radiation can no longer cure. Hycamtin capsules are approved only for small cell lung cancer that relapses at least 45 days after first-line chemotherapy ended, in people whose cancer had shrunk with that first treatment. Topotecan is generally used to control the cancer, extend life and ease symptoms rather than to cure it.

How It Works

To copy its DNA before dividing, a cell has to unwind the tightly coiled strands. An enzyme called topoisomerase I relieves that tension by making a temporary cut in one strand and then resealing it. Topotecan binds to the enzyme while it is attached to DNA and stops the resealing step. When the cell then tries to copy that stretch of DNA, the unsealed cuts turn into breaks across both strands, which cells cannot repair well, and the cell dies. Cancer cells that divide rapidly are especially exposed. Healthy fast-dividing cells, such as those in the bone marrow, the gut lining and hair follicles, are affected too, which explains the main side effects.

Dosage & Administration

Topotecan is given in cycles that repeat every 21 days. The dose is calculated from body surface area (based on height and weight) and adjusted for kidney function, since reduced kidney function means a lower dose. The IV form is given as a 30-minute infusion at a cancer clinic or hospital. For ovarian and small cell lung cancer, it is usually given on five days in a row, followed by about two weeks off. For cervical cancer, it is given on three days in a row, with cisplatin on the first day. Hycamtin capsules are taken at home once a day, with or without food, for five days in a row at the start of each 21-day cycle. Swallow the capsules whole and do not chew, crush or divide them. If a dose is missed or vomited, do not take an extra dose; take the next one at the usual time. Because topotecan is a chemotherapy drug, ask the care team how to handle and store the capsules safely at home. Before each new cycle, blood tests confirm that blood counts have recovered enough. The next cycle may be delayed, or the dose lowered, if counts are still low or side effects were severe.

Side Effects

The most important effect is on the bone marrow, which makes blood cells. Topotecan carries an FDA boxed warning, the agency's most prominent warning, for severe drops in blood counts. White blood cell counts usually reach their lowest point about two weeks after a cycle starts, and during that window infections can become serious quickly. Low platelets can cause easy bruising or bleeding, and low red blood cells (anemia) cause tiredness and breathlessness; some people need transfusions. Other common side effects include nausea, vomiting, diarrhea, fatigue, loss of appetite and hair thinning or hair loss. With the capsules, diarrhea can become severe enough to need hospital care, especially when it happens at the same time as low blood counts. The care team usually explains which anti-diarrhea medicine to start at the first loose stool. Call the care team right away for a fever, such as a temperature of 100.4°F (38°C) or higher, chills or other signs of infection; for unusual bleeding or bruising; for belly pain together with fever, which can signal a rare but dangerous bowel inflammation during low counts; or for diarrhea that does not settle with the recommended treatment. New or worsening cough or shortness of breath also needs a prompt call, because topotecan can rarely cause a serious inflammation and scarring of the lungs called interstitial lung disease. With the IV form, tell the nurse at once about pain, burning or swelling at the infusion site, since the drug can damage tissue if it leaks out of the vein.

Interactions & Warnings

Topotecan can harm a developing baby. Women who could become pregnant should use effective contraception during treatment and for 6 months after the last dose, and men with a partner who could become pregnant should use it during treatment and for 3 months after. Tell the care team right away about a known or possible pregnancy. Breastfeeding should stop during treatment and for 1 week after the last dose. Topotecan may also reduce fertility in both men and women, which is worth discussing before treatment if future children matter. The risk of lung problems is higher in people who have had lung disease or lung scarring, chest radiation, lung cancer, or certain other medicines that can injure the lungs. Anyone who has had a severe allergic reaction to topotecan should not receive it again. For Hycamtin capsules, some medicines block the proteins (P-glycoprotein, or P-gp, and breast cancer resistance protein, or BCRP) that normally help move topotecan out of the body. Taking these together can raise topotecan levels and increase side effects, so they are generally avoided. Examples include cyclosporine, a transplant medicine. Give the care team and pharmacist a full list of prescriptions, over-the-counter medicines and supplements before starting.

What to Expect

Treatment usually continues cycle by cycle for as long as the cancer is controlled and side effects are manageable. Expect frequent blood tests, often weekly in the early cycles, and scans every few cycles to check whether the cancer is shrinking, stable or growing. Fatigue may limit activity, and the days around the lowest blood counts usually call for extra care to avoid infection. Topotecan helps some people but not everyone. In the study that led to approval of the capsules, people with relapsed small cell lung cancer who took them lived a median of about 6 months, compared with about 3 months with supportive care alone. In advanced cervical cancer, adding topotecan to cisplatin raised median survival from about 6.5 to 9.4 months. In recurrent ovarian cancer, roughly 1 in 5 people saw their tumors shrink, with results similar to the chemotherapy drug paclitaxel. Responses, when they happen, often appear within the first two or three cycles. If the cancer grows or side effects become too hard, the care team will discuss other treatments, clinical trials or a focus on comfort care.

Questions to Ask Your Doctor

  1. 1.What do we hope topotecan will achieve for my cancer, and how will we know whether it is working?
  2. 2.Is the IV form or the capsule form better for me, and what other treatment options do I have at this point?
  3. 3.When will my blood counts be at their lowest, and what temperature or symptoms should make me call you, including after hours?
  4. 4.How should we manage diarrhea, nausea and fatigue, and which medicines should I keep at home?
  5. 5.Do any of my current medicines or supplements interact with topotecan, and what do I need to know about contraception or fertility?

Last reviewed • Oct 2026

Educational content, not medical advice.